These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12899532

  • 1. Vitamin D analogs and breast cancer.
    O'Kelly J, Koeffler HP.
    Recent Results Cancer Res; 2003; 164():333-48. PubMed ID: 12899532
    [Abstract] [Full Text] [Related]

  • 2. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA.
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [Abstract] [Full Text] [Related]

  • 3. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC, Chen SC, Yeh CN, Pang JH, Shen SC, Hsu JT, Liu YY, Chen LW, Kuo SF, Takano M, Kittaka A, Sun CC, Juang HH, Chen TC.
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [Abstract] [Full Text] [Related]

  • 4. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D and vitamin D analogs in cancer treatment.
    van den Bemd GJ, Chang GT.
    Curr Drug Targets; 2002 Feb 01; 3(1):85-94. PubMed ID: 11899952
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D and breast cancer.
    Christakos S.
    Adv Exp Med Biol; 1994 Feb 01; 364():115-8. PubMed ID: 7725955
    [Abstract] [Full Text] [Related]

  • 7. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 01; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 8. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
    Leyssens C, Verlinden L, Verstuyf A.
    Endocr Relat Cancer; 2013 Apr 01; 20(2):R31-47. PubMed ID: 23319494
    [Abstract] [Full Text] [Related]

  • 9. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
    Bouillon R, Verstuyf A, Branisteanu D, Waer M, Mathieu C.
    Verh K Acad Geneeskd Belg; 1995 Apr 01; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ, Vanweelden K, Byrne I, Welsh J.
    Endocrinology; 1996 Feb 01; 137(2):400-9. PubMed ID: 8593782
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 12. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP.
    Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602
    [Abstract] [Full Text] [Related]

  • 13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Aug 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 14. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Aug 15; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 15. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 Aug 15; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 17. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D and breast cancer: emerging concepts.
    Mehta RG, Peng X, Alimirah F, Murillo G, Mehta R.
    Cancer Lett; 2013 Jun 28; 334(1):95-100. PubMed ID: 23142286
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.
    Mehta RR, Bratescu L, Graves JM, Green A, Mehta RG.
    Int J Oncol; 2000 Jan 28; 16(1):65-73. PubMed ID: 10601550
    [Abstract] [Full Text] [Related]

  • 20. The anti-cancer actions of vitamin D.
    Chiang KC, Chen TC.
    Anticancer Agents Med Chem; 2013 Jan 28; 13(1):126-39. PubMed ID: 23094926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.